Skip to main content

An Update on CSL's Sustainability Journey

CSL Chief Sustainability Officer Jeffrey Ball looks ahead to Earth Day on April 22 and shares highlights, including CSL’s renewable-linked power purchase agreement in Australia and the company’s plan to submit emissions targets for validation in July.


As Earth Day approaches, CSL is reflecting on recent accomplishments while also looking ahead to what’s next: seeking the validation of its emissions targets by the Science Based Targets Initiative (SBTi), Chief Sustainability Officer Jeffrey Ball said.

SBTi is a nonprofit collaboration that has helped guide thousands of businesses to choose emissions targets. CSL seeks to submit its targets in July, Ball said in a video message.

CSL Chief Sustainability Officer Jeffrey Ball

Ball also shared strides CSL has made so far, including an agreement finalized in October with Australian energy supplier AGL. In the seven-year agreement, CSL will match 100% of the electricity used by its Australian manufacturing sites with renewable energy certificates. The company has also achieved 100% renewable electricity purchased from certified sources across its European manufacturing facilities.

CSL is a global biotech that includes business units CSL Behring, which makes medicines for people who have rare and serious diseases; CSL Seqirus, which develops and manufactures vaccines; and CSL Vifor, a leader in iron deficiency and nephrology (kidney care).